Rh4 inhibits colorectal cancer (CRC) cell proliferation by activating ROS/p53 signaling pathway, up-regulating p53 expression activates autophagy, downregulates GPX4, SLC7A11, and induces ferroptosis (Wu et al., 2022). This evidence concerns the gene TP53 and colorectal carcinoma.